Pasithea Therapeutics
(NASDAQ:KTTA)
$8.6301
1.4801[20.70%]
At close: Apr 8
$8.6301
0[0.00%]
After Hours: 5:46PM EDT
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Rating
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Pasithea Therapeutics Corp
Sector
Health Care
Industry
Biotechnology
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
KTTA
VIRI

FAQ

Q

How do I buy Pasithea Therapeutics (KTTA) stock?

A

You can purchase shares of Pasithea Therapeutics (NASDAQ: KTTA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Pasithea Therapeutics's (KTTA) competitors?

Q

What is the target price for Pasithea Therapeutics (KTTA) stock?

A

The latest price target for Pasithea Therapeutics (NASDAQ: KTTA) was reported by EF Hutton on Monday, July 10, 2023. The analyst firm set a price target for 2.00 expecting KTTA to fall to within 12 months (a possible -76.83% downside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Pasithea Therapeutics (KTTA)?

A

The stock price for Pasithea Therapeutics (NASDAQ: KTTA) is $8.6301 last updated April 8, 2024 at 5:46 PM EDT.

Q

Does Pasithea Therapeutics (KTTA) pay a dividend?

A

There are no upcoming dividends for Pasithea Therapeutics.

Q

When is Pasithea Therapeutics (NASDAQ:KTTA) reporting earnings?

A

Pasithea Therapeutics’s Q1 earnings are confirmed for Friday, May 10, 2024.

Q

Is Pasithea Therapeutics (KTTA) going to split?

A

There is no upcoming split for Pasithea Therapeutics.

Q

What sector and industry does Pasithea Therapeutics (KTTA) operate in?

A

Pasithea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch